Genomics is a holistic study of the DNA of an organism to comprehend the gene structure, functionality, and development, rendering the innovations of disease prediction, clinical tailoring, and research laboratory usage. Besides mediating the genetic risks, it unlocks the secrets of biomarkers, proceeds drug response, and facilitates the use of molecular diagnostics, pharmacogenomics, and functional genomics, which are the mainstays of patient care and targeted therapeutics.
Key Growth Drivers and Opportunities
Advancements in Disease Prediction Technologies: One of the factors leading to the growth of the genomics market is the development of cutting-edge technologies such as next-generation sequencing, which allow a speedy, low-cost genome analysis and accurate disease prediction. Using genomic data along with other omics is more effective in identifying the genetic biomarkers, the risk factors, and the complex interactions, thus providing the clinicians with the accurate information necessary for the personalized healthcare.
Challenges
The genomics market is suffering from several limitations as the high cost of sequencing technologies, the complexity of data analysis, the shortage of qualified professionals, the fear of ethical and privacy issues, and regulatory problems. All these issues can hold back the spread of using genomics widely.
Innovation and Expansion
Imperial Established the Functional Genomics Network to Boost Translational Research
In August 2024, The Royal Geographic Society hosted a celebration gathering last month to officially establish the Imperial Excellence in Functional Genomics Network. Researchers, doctors, and academics from Imperial College London and its partner institutions gathered for an afternoon of talks, discussions, and networking.
The Network’s goal is to bring these strengths together, encouraging collaboration, simplifying resources, and expediting the translation of genomic discoveries into real-world applications.
Suraksha Diagnostics Opens Genomics Lab in Eastern India with ₹22 Crore Investment
In July 2025, Suraksha Diagnostics has opened a genomics laboratory in Kolkata, making it one of the largest such facilities in Eastern India. The laboratory is equipped with cytogenetics, microarray, Sanger sequencing, and several next-generation sequencing (NGS) systems. These systems support a wide spectrum of genetic testing for predictive, preventative, and personalized therapy.
Suraksha’s genomics lab offers prenatal genetic screening for Down syndrome, Edwards syndrome, Patau syndrome, and other chromosomal disorders. These services are supplemented by genetic counselling to help expectant families make informed decisions.
Inventive Sparks, Expanding Markets
Key players in the genomics market include Thermo Fisher Scientific, Agilent Technologies, Illumina, Eurofins Scientific, QIAGEN (Netherlands), BGI, GE Healthcare, Bio-Rad Laboratories, F. Hoffmann-La Roche, Oxford Nanopore Technologies, Pacific Biosciences of California, and Eppendorf, among others.
About Author:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.
